By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
Since going digital in 2020, RESI conferences have been able to grow and meet the unique needs of virtual partnering in many ways, but few more exciting than the Innovator’s Pitch Challenge (IPC). The IPC is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Participating companies pay registration and a $500 pitching fee to host their company materials on the Live Agenda and participate in the live pitch session.
Applications are due October 22, but those who apply by October 8 save an additional $200 with super early bird registration rates. Hear from past participants about their experiences pitching at RESI conferences and how their experiences contributed to their global fundraising efforts.
- Jonathan Cohen, 20/20 Gene Systems
- Andrea Wang, AHEAD Medicine
- Marc Rippen, Alertgy
- Michael Simon, Creative Bio-Peptides
- Buddy Lyons, Entac Medical
- Beth Sanders, LifeBio
- Anthony Desir, Moexa
- Edison Hudson, Panacea BioMatx
- Pepper Landson, Praetego
- Richard Austin, Reglagene
Next Phase Newsletter 
Leave a comment